Glutamate, Brain Connectivity and Duration of Untreated Psychosis (DUP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02034253|
Recruitment Status : Completed
First Posted : January 13, 2014
Last Update Posted : January 22, 2019
University of Alabama at Birmingham
Information provided by (Responsible Party):
Dr. Adrianne C Lahti, University of Alabama at Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||November 2018|
|Actual Study Completion Date :||November 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Maximo JO, Nelson EA, Armstrong WP, Kraguljac NV, Lahti AC. Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Feb;5(2):231-238. doi: 10.1016/j.bpsc.2019.10.014. Epub 2019 Nov 9.
Kraguljac NV, Anthony T, Skidmore FM, Marstrander J, Morgan CJ, Reid MA, White DM, Jindal RD, Melas Skefos NH, Lahti AC. Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 May;4(5):462-471. doi: 10.1016/j.bpsc.2019.01.002. Epub 2019 Jan 23.